Point72 Asset Management L.P. Has $50.09 Million Stock Holdings in Hill-Rom Holdings, Inc. (NYSE:HRC)

Point72 Asset Management L.P. grew its stake in Hill-Rom Holdings, Inc. (NYSE:HRC) by 3.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 453,363 shares of the medical technology company’s stock after buying an additional 13,147 shares during the period. Point72 Asset Management L.P.’s holdings in Hill-Rom were worth $50,088,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of HRC. Arkadios Wealth Advisors grew its stake in Hill-Rom by 928.6% during the first quarter. Arkadios Wealth Advisors now owns 288 shares of the medical technology company’s stock worth $31,000 after purchasing an additional 260 shares during the period. Central Bank & Trust Co. acquired a new stake in Hill-Rom during the first quarter worth approximately $40,000. Ameritas Investment Company LLC acquired a new stake in Hill-Rom during the first quarter worth approximately $119,000. Exane Derivatives acquired a new stake in Hill-Rom during the first quarter worth approximately $148,000. Finally, Windsor Group LTD acquired a new stake in Hill-Rom during the first quarter worth approximately $211,000. 83.61% of the stock is owned by institutional investors.

In other news, SVP Deborah Rasin sold 10,223 shares of the firm’s stock in a transaction that occurred on Monday, June 7th. The stock was sold at an average price of $110.67, for a total value of $1,131,379.41. Following the transaction, the senior vice president now owns 30,432 shares in the company, valued at $3,367,909.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.69% of the stock is owned by company insiders.

Shares of Hill-Rom stock opened at $118.62 on Thursday. The company has a quick ratio of 1.20, a current ratio of 1.61 and a debt-to-equity ratio of 0.89. Hill-Rom Holdings, Inc. has a 52 week low of $80.31 and a 52 week high of $118.87. The firm has a 50 day moving average price of $113.15. The firm has a market capitalization of $7.88 billion, a PE ratio of 28.18, a PEG ratio of 2.46 and a beta of 0.57.

Hill-Rom (NYSE:HRC) last announced its quarterly earnings data on Friday, April 30th. The medical technology company reported $1.73 EPS for the quarter, beating the Zacks’ consensus estimate of $1.43 by $0.30. Hill-Rom had a return on equity of 24.48% and a net margin of 9.48%. The firm had revenue of $762.00 million during the quarter, compared to analysts’ expectations of $732.20 million. During the same quarter last year, the firm posted $1.28 earnings per share. The company’s revenue for the quarter was up 5.4% compared to the same quarter last year. As a group, analysts expect that Hill-Rom Holdings, Inc. will post 6.06 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 30th. Stockholders of record on Friday, September 17th will be issued a $0.24 dividend. The ex-dividend date of this dividend is Thursday, September 16th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.81%. Hill-Rom’s dividend payout ratio is presently 17.36%.

Several research firms recently commented on HRC. Robert W. Baird raised their target price on Hill-Rom from $115.00 to $125.00 and gave the stock an “outperform” rating in a research note on Monday, May 3rd. Raymond James raised their price objective on Hill-Rom from $120.00 to $122.00 and gave the company an “outperform” rating in a research note on Monday, May 3rd. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Hill-Rom currently has a consensus rating of “Buy” and a consensus target price of $121.80.

Hill-Rom Company Profile

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates through Patient Support Systems, Front Line Care, and Surgical Solutions segments. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, patient mobility solutions, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment.

Featured Story: Different Types of Derivatives

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.